AFC
PRAX icon

Ares Financial Consulting’s Praxis Precision Medicines PRAX Stock Holding History

Ares Financial Consulting’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35K Buy
+13
New +$4.12K ﹤0.01% 744

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ares Financial Consulting's PRAX Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 13 shares worth $4.35K. The stake represents ﹤0.01% of the portfolio and ranks #744 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Ares Financial Consulting held 13 shares of Praxis Precision Medicines worth $4.35K as of Q2 2026.
  • Praxis Precision Medicines was a new Ares Financial Consulting position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #744 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.